Compare BBOT & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBOT | HBNC |
|---|---|---|
| Founded | 2016 | 1873 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 883.5M |
| IPO Year | N/A | N/A |
| Metric | BBOT | HBNC |
|---|---|---|
| Price | $12.04 | $18.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $23.83 | $20.33 |
| AVG Volume (30 Days) | 272.8K | ★ 378.7K |
| Earning Date | 02-26-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 3.48% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $51.78 |
| Revenue Next Year | N/A | $10.63 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.91 |
| 52 Week Low | $8.50 | $12.70 |
| 52 Week High | $14.87 | $19.07 |
| Indicator | BBOT | HBNC |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 54.86 |
| Support Level | $10.08 | $17.82 |
| Resistance Level | $12.01 | $18.84 |
| Average True Range (ATR) | 1.05 | 0.51 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 48.59 | 60.61 |
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.